Lixte Biotechnology Holdings Inc. Common Stock (LIXT)

FairStock Score: 20/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach Lixte as a Graham-style analyst: I want proven earnings, honest book value, and a margin of safety. The data show a $44.0M market cap and a $3.71 close on 2026-09-02. It is a money-losing enterprise: FairStock's P/E is -2.94, P/B is 4.12, ROE is -101.95%, and ROCE is -46.00%. Trailing free cash flow is -$4.4M, for a -9.9% FCF yield. The provided profit growth is -171.11%, though no fiscal period is specified; revenue growth is N/A. The Piotroski F-Score is 0/9 and the FairStock Score is 20/100. The Lynch category is none because there are only 0 years of filed results, needing 3. On the positive side, debt is low with D/E 0.09 and the Altman Z-Score is 8.17. Beta is 1.05. But low leverage does not create a moat. The business description lists Traveler, a 1 MW/2 MWh mobile battery storage system, and Voyager Falcon for peak shaving and load shifting. That could be interesting if commercialized, but the numbers show no evidence yet. Paying 4.12 times book for negative returns and cash burn is not cheap in Graham terms. I would need revenue, positive cash flow, and a multi-year record before calling this a durable business.

In plain English: Lixte Biotechnology Holdings is described as developing mobile, utility-scale battery storage systems. The business looks weak based on the numbers provided: it is losing money, burning cash, and has low overall fundamental scores. At $3.71 on 2026-09-02, the price looks expensive relative to current profits and book value because there are no positive earnings to support it.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-09-02 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer